Evotec SE (OTCMKTS:EVTCY – Get Free Report)’s share price reached a new 52-week low on Monday . The stock traded as low as $5.17 and last traded at $5.20, with a volume of 226635 shares trading hands. The stock had previously closed at $5.02.
Evotec Stock Up 3.6 %
The firm has a market capitalization of $1.72 billion, a price-to-earnings ratio of 56.00 and a beta of 0.98. The company has a debt-to-equity ratio of 0.53, a current ratio of 2.57 and a quick ratio of 2.50. The business has a fifty day moving average price of $7.28 and a two-hundred day moving average price of $8.64.
About Evotec
Evotec SE engages in the discovery and development of new drugs for pharmaceutical and biotechnology companies. It operates through the following segments: EVT Execute and EVT Innovate. The EVT Execute segment provides stand-alone or integrated drug discovery solutions for collaborators targets and programmers on a typical fee-for-service basis or through a variety of commercial structures, which may include performance-based components, such as milestones and royalties.
Featured Articles
- Five stocks we like better than Evotec
- What Are Trending Stocks? Trending Stocks Explained
- The 3 Hottest Insiders Buys This Month
- Find and Profitably Trade Stocks at 52-Week Lows
- What Bulls and Bears May Be Getting Wrong about SOFI Stock
- NYSE Stocks Give Investors a Variety of Quality Options
- Microsoft Analysis: Trends, Predictions & Investment Insight
Receive News & Ratings for Evotec Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Evotec and related companies with MarketBeat.com's FREE daily email newsletter.
